Methicillin-resistant Staphylococcus aureus colonization in inflammatory versus non-inflammatory skin diseases: Who should be screened?

Acta Dermato-Venereologica

Volumn 84, Issue 3, 2004, Pages 181-186

  Jappe, Uta ^a   Petzoldt, Detlef ^a   Wendt, Constanze ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Basal cell carcinoma; Inflammatory skin diseases; Venous leg ulcers

Indexed keywords

GENTAMICIN; PSEUDOMONIC ACID; RESTRICTION ENDONUCLEASE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BASAL CELL CARCINOMA; CONTROLLED STUDY; EROSION; FEMALE; HUMAN; INFECTION CONTROL; LEG ULCER; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; SCREENING; SKIN DISEASE; SKIN INFLAMMATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARRIER STATE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; METHICILLIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN DISEASES; SKIN NEOPLASMS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 2442634108     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410025255     Document Type: Article

References (49)

1. Williams RE, MacKie RM. The staphylococci. Importance of their control in the management of skin disease. Dermatol Clin 1993; 11: 201-206.
2. Jappe U. Superantigens and their association to dermatological inflammatory diseases: facts and hypotheses. Acta Derm Venereol 2000; 80: 321-328.
3. Feingold DS, Wagner RF Jr. Antibacterial therapy. J Am Acad Dermatol 1986; 14: 535-548.
4. Colsky AS, Kisner R, Kerdel F. Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol 1998; 134: 1006-1009.
5. Panlilio AL. Methicillin-resistant S. aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13: 582-586.
6. Rosdahl VT. Microbiology and resistance in skin infections. J Eur Acad Dermatol Venereol 1998; 11 (Suppl 2): S83.
7. Nishijima S, Namura S, Mitsuya K, Asada Y. The incidence of isolation of methicillin-resistant S. aureus (MRSA) strains from skin infections during the past three years (1989-1991). J Dermatol 1993; 20: 193-197.
8. Yamagushi T, Yokota Y, Terajima J, Hayashi T, Aepfelbacher M, Ohara M, et al. Clonal association of S. aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 2002; 185: 1511-1516.
9. Ewing CI, Ashcroft C, Gibbs ACC, Jones GA, Connor PJ, David TJ. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998; 138: 1022-1029.
10. Arkwright PD, Daniel TO, Sanyal D, David TJ, Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-speciality center. Arch Dermatol 2002; 138: 939-941.
11. Kresken M, Hafner D. Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft "Resistenz" in der Paul-Ehrlich-Gesellschaft für Chemotherapie aus dem Jahr 1995. Chemother J 1996; 5: 225-230.
12. Kresken M, Hafner D. Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft "Resistenz" in der Paul-Ehrlich-Gesellschaft für Chemotherapie aus dem Jahr 1998. http://www.p-e-g-de
13. Kresken M, Schmitz FJ, Haffner D, Wichelhaus T. Erste Ergebnisse der PEG-Resistenzsituation 2001, Paul-Ehrlich-Gesellschaft für Chemotherapie in Epidemiologisches Bulletin 2003; 19: 145-148.
14. Tebbe B, Wagner J, Orfanos CE. Erregerspektrum von Hautinfektionen und Resistenzverhalten von S. aureus und Pseudomonas aeroginosa. Zeitschr Hautkr 1995; 70: 38-42.
15. Voss A, Machka A, Lenz W, Milatovic D. Vorkommen, Häufigkeit und Resistenzverhalten von Methicillin-Oxacillin-resistenten S. aureus-Stämmen in Deutschland. Dtsch Med Wochenschr 1992; 117: 1907-1912.
16. McBride ME, Schaefer D, Rudolph AH, Aldama S, Wolf JE Jr. Evaluation of antibacterial sensitivity testing methods for methicillin-resistant S. aureus in a dermatology outpatient population. South Med J 1989; 82: 165-168.
17. Price MF, McBride ME, Wolf JE Jr. Prevalence of methicillin-resistant S. aureus in a dermatology outpatient population. South Med J 1998; 91: 369-371.
18. Kluytmans J von, Belkum A van, Verbrugh H. Nasal carriage of S. aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-520.
19. Working party report: Revised guidelines for the control of methicillin-resistant S. aureus infection in hospitals. J Hosp Infect 1998; 39: 253-290.
20. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. Centers for Disease Control definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
21. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Villanova, PA: National Committee for Clinical Laboratory Standards, 2001.
22. Pfaller M, Hollis RJ, Sader HS. PFGE of chromosomal DNA. In: Isenberg HD, ed. Clinical microbiological procedures handbook. Washington, DC: American Society for Microbiology, 1992: Section 10.5.c.
23. Witte W. Staphylokokken-Infektionen: NRZ zur Situation in Deutschland im Jahr 2001. Epidemiolisches Bulletin 2002; 8: 61-63.
24. Witte W, Braulke Ch, Heuck D. MRSA-Situation in Deutschland. Hyg Med 2000; 25: 34-35.
25. Moreno F, Crisp C, Jorgensen J, Patterson JE. Methicillin-resistant S. aureus as a community organism. Clin Infect Dis 1995; 21: 1308-1312.
26. Givney R, Vickery A, Holliday A, Pegler M, Benn R. Methicillin-resistant S. aureus in a cystic fibrosis unit. J Hosp Infect 1997; 35: 27-36.
27. Witte W, Cuny C, Braulke C, Heuck D, Klare I. Widespread dissemination of epidemic MRSA in German hospitals. EuroSurveillance 1997; 2: 25-28.
28. Barrett SP, Teare EL, Sage R. Methicillin-resistant S. aureus in three adjacent Health Districts of south-east England 1986-1991. J Hosp Infect 1993; 24: 313-325.
29. Fraise AP, Mitchell K, O'Brien SJ, Oldfield K, Wise R. Methicillin-resistant S. aureus (MRSA) in nursing homes in a major UK city: an anonymized point prevalence survey. Epidemiol Infect 1997; 118: 1-5.
30. Sa-Leao R, Santos Sanches I, Couto I, Rute Alves C, De Lencastre H. Low prevalence of methicillin-resistant strains among S. aureus colonising young and healthy members of the community in Portugal. Microb Drug Resist 2001; 7: 237-245.
31. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant S. aureus in two child care centers. J Infect Dis 1998; 178: 577-580.
32. CDC. Four pediatric deaths from community-acquired methicillin-resistant S. aureus - Minnesota and North Dakota, 1997-1999. MMWR Morbid Mortal Wkly Rep 1999; 48: 707-710.
33. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant S. aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999; 29: 797-800.
34. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant S. aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-598.
35. Lindenmayer JM, Schoenfeld S, Grady RO, Carney JK. Methicillin-resistant S. aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998; 158: 895-899.
36. OBrien FG, Pearman M, Gracey M, Riley TV, Grubb WB. Community strain of methicillin-resistant S. aureus involved in a hospital outbreak. J Clin Microbiol 1999; 37: 2858-2862.
37. Witte W, Kresken M, Braulke C, Cuny C. Increasing incidence and widespread dissemination of methicillin-resistant S. aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin Microbiol Infect 1997; 3: 414-422.
38. Witte W, Cuny C, Braulke C, Heuck D, Klare I, Werner G. Emergence and spread of multiresistant S. aureus and Enterococcusfaecium: consequences for prevention. Nova Acta Leopoldina NF 1999; 78: 51-67.
39. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-797.
40. Layton MC, Perez M, Heald P, Patterson JE. An outbreak of mupirocin-resistant S. aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993; 14: 369-375.
41. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. Community acquired, non-multiresistant oxacillin-resistant S. aureus ("NORSA") in South Western Sydney. Pathology 2001; 33: 206-210.
42. Gosbell IB, Mercer JL, Neville SA, Crone SA, Chant KG, Jalaludin BB, et al. Nonmultiresistant and multiresistant methicillin-resistant S. aureus in community-acquired infections. Med J Aust 2001; 174: 627-630.
43. Peltroche-Llacsahuanga H, Haase G, Lütticken R. Methicillin-resistant S. aureus (MRSA) - clinical implications. Chirurg 1998; 69: 801-805.
44. Trividic M, Gauthier ML, Sparsa A, Ploy MC, Mounier M, Boulinguez S, et al. S. aureus methi-resistant en dermatologie: provenance du germe, facteurs de risque, et evolution. Ann Dermatol Venereol 2002; 129: 27-29.
45. Frank AL, Marcinak JF, Mangat PD, Schreckenberger PC. Community-acquired and clindamycin-susceptible methicillin-resistant S. aureus in children. Pediatr Infect Dis J 1999; 18: 993-1000.
46. Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Looker DN. All Wales surveillance of methicillin-resistant S. aureus (MRSA): the first years results. J Hosp Infect 1999; 41: 173-179.
47. Akiyama H, Yamasaki O, Tada J, Arata J. Adherence characteristics and susceptibility to antimicrobial agents of S. aureus strains isolated from skin infections and atopic dermatitis. J Dermatol Sci 2000; 23: 155-160.
48. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and S. aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29-34.
49. Korting HC, Neubert U, Abeck D. Current antimicrobial susceptibility of cutaneous bacteria to first line antibiotics. Int J Antimicrob Agents 1998; 10: 165-168.